In summary, we have shown that, among the EGFR family members, only HER-2 is an independent prognostic factor of endometrioid-type endometrial cancer, which may link to the PI3K–AKT pathway, independent of PTEN mutation or mismatch repair deficiency. The gene discussed is ERBB2; the disease is endometrial cancer.